DiscovertHEORetically SpeakingINsights & OUTcomes with Vernon Schabert
INsights & OUTcomes with Vernon Schabert

INsights & OUTcomes with Vernon Schabert

Update: 2025-04-28
Share

Description

Welcome to INsights & OUTcomes, the newest podcast on tHEORetically Speaking from HealthEconomics.com, where we sit down with the leading professionals in HEOR, RWE, and market access, the experts shaping the future of healthcare decisions.

This episode features Dr. Vernon Schabert, Founder of Epilogix. Vernon is an internationally-recognized health economist and pharmacoepidemiologist and has nearly 30 years of HEOR, RWD, and RWE industry experience.

To stay connected with us, visit our LinkedIn page and subscribe to our newsletter!

Learn more about Epilogix: https://healtheconomics.com/suppliers/epilogix-llc/

Introducing Trial Insights—the essential tool for pharma researchers and biotech investors. 

Seamlessly track clinical trials in real-time, refine searches by key criteria, and receive timely notifications on important updates. With Trial Insights, ensure your research and business initiatives are always informed and strategically positioned for success. 

Start exploring thousands of trials today at trialinsights.com

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

INsights & OUTcomes with Vernon Schabert

INsights & OUTcomes with Vernon Schabert

HealthEconomics.com